BUY | SELL | ||
---|---|---|---|
QTY | PRICE | PRICE | QTY |
4 | 915.00 | 922.90 | 5 |
10 | 914.00 | 923.00 | 146 |
3 | 913.65 | 932.00 | 10 |
1 | 913.00 | 936.00 | 8 |
100 | 912.00 | 940.00 | 100 |
0 | Total | Total | 0 |
BUY | SELL | ||
---|---|---|---|
QTY | PRICE | PRICE | QTY |
4 | 915.00 | 922.90 | 5 |
10 | 914.00 | 923.00 | 146 |
3 | 913.65 | 932.00 | 10 |
1 | 913.00 | 936.00 | 8 |
100 | 912.00 | 940.00 | 100 |
0 | Total | Total | 0 |
Open | 940.15 |
Previous Close | 940.15 |
Volume | 22,180.00 |
Value (Lacs) | 204.31 |
VWAP | 920.72 |
Beta | |
Mkt Cap (Rs. Cr.) | 1,931 |
High | 949.00 |
Low | 911.05 |
UC Limit | 1,128.15 |
LC Limit | 752.15 |
52 Week High | 1,198.25 |
52 Week Low | 665.10 |
Face Value | 5.00 |
All Time High | 1,198.25 |
All Time Low | 203.25 |
20D Avg Volume | 93,048 |
20D Avg Delivery(%) | 23.09 |
Book Value Per Share | 224.83 |
Dividend Yield | 0.63 |
TTM EPS See historical trend | 31.10 (+8.54% YoY) |
TTM PE See historical trend | 29.62 (Average PE) |
P/B See historical trend | 4.10 (High P/B) |
Sector PE | 38.97 |
*Delayed by 20 seconds.
Stock Score
Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
---|---|---|---|---|---|---|---|
Classic | - - | - - | - - | - - | - - | - - | - - |
Fibonacci | - - | - - | - - | - - | - - | - - | - - |
Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
R1 | - - | Pivot - - |
S1 | - - |
R2 | - - | S2 | - - | |
R3 | - - | S3 | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
Days | |
---|---|
5 | - - |
10 | - - |
20 | - - |
50 | - - |
100 | - - |
200 | - - |
Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
---|---|---|---|---|---|---|---|
Classic | - - | - - | - - | - - | - - | - - | - - |
Fibonacci | - - | - - | - - | - - | - - | - - | - - |
Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
R1 | - - | Pivot - - |
S1 | - - |
R2 | - - | S2 | - - | |
R3 | - - | S3 | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
Days |
---|
Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
---|---|---|---|---|---|---|---|
Classic | - - | - - | - - | - - | - - | - - | - - |
Fibonacci | - - | - - | - - | - - | - - | - - | - - |
Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
R1 | - - | Pivot - - |
S1 | - - |
R2 | - - | S2 | - - | |
R3 | - - | S3 | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
Days |
---|
1 Week | --% | |
1 Month | --% | |
3 Months | --% | |
YTD | --% | |
1 Year | --% | |
3 Years | --% |
3 out of 5 years Windlas Biotech has given negative returns in October.
Month | Max. Positive Change(%) | Avg. Positive Change(%) | Max. Negative Change(%) | Avg. Negative Change(%) | Average Change(%) |
---|---|---|---|---|---|
October | 33.50% (2024) | 17.59% | -14.58% (2021) | -8.02% | 2.22% |
Windlas Biotech Standalone June 2025 Net Sales at Rs 210.09 crore, up 19.95% Y-o-Y Sep 10 2025 11:06 AM
Windlas Biotech to Hold Analyst/Investor Meeting on September 3, 2025 Aug 28 2025 01:16 PM
Windlas Biotech Consolidated March 2025 Net Sales at Rs 202.71 crore, up 18.34% Y-o-Y May 27 2025 12:03 PM
Windlas Biotech Standalone March 2025 Net Sales at Rs 202.71 crore, up 18.34% Y-o-Y May 23 2025 10:20 AM
*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.
Qty 144995 | Price 787.42 | % Traded 0.68 |
Qty 115374 | Price 683.49 | % Traded 0.56 |
*A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.
Date | Agenda |
---|
Ex-Date | Type | Dividend (Rs) |
---|
Announcement Date | Ex-Bonus | Ratio |
---|
Ex-Split | Old FV | New FV |
---|
Ex-Right | Ratio | Premium |
---|
Date | Agenda |
---|
Company Name | Price | % Chg | MCap(Cr) | TTM PE | P/B | ROE(%) | 1 Yr Perform(%) | Net Profit(Rs.) | Net Sales(Rs.) | Debt to Equity |
---|---|---|---|---|---|---|---|---|---|---|
Windlas Biotech | 921.15 | -2.02 | 1,930.67 | 29.78 | 4.09 | 11.99 | 4.21 | 60 | 759 | 0.05 |
Biocon | 347.75 | -1.28 | 46,492.91 | 120.75 | 2.21 | 4.68 | 0.40 | 1,429 | 15,261 | 0.82 |
Concord Biotech | 1,620.50 | 1.47 | 16,953.06 | 47.45 | 10.66 | 20.57 | -15.65 | 372 | 1,200 | 0.00 |
Sun Pharma Adv | 131.91 | -0.15 | 4,280.76 | - | - | 0.00 | -37.31 | -342 | 71 | -1.19 |
Softrak Venture | 2.28 | -0.44 | 102.78 | 228.00 | 2.26 | 0.78 | -20.00 | 0 | 2 | 0.00 |